摘要
目的探讨奎硫平治疗女性精神分裂症患者的疗效和安全性。方法奎硫平治疗30例女性精神分裂症,以阳性与阴性症状量表(PANSS)评定疗效,以不良反应量表(TESS)评定安全性。结果奎硫平治疗女性精神分裂症显效率66.67%,有效率83.33%。不良反应轻。结论奎硫平对女性精神分裂症有较好的疗效和安全性。
Objective Discussion quetiapine in the treatment of female patients with schizophrenia efficacy and safety. Methods Quetiapine in the treatment of 30 cases of female schizophrenia, with positive and negative symptom scale (PANSS) to evaluate the efficacy, adverse reactions to scale (TESS) for security. Results Quetiapine in the treatment of female schizophrenia, significant efficiency of 66.67%, 83.33% efficiency, adverse reactions. Conclusion Quetiapine for women with schizophrenia have better efficacy and safety,
出处
《中华临床医学杂志》
2008年第1期27-28,共2页
Chinese Journal of Clinical Practical Medicine